LEUKOCARE has been granted both ISO 9001 and ISO 13485 certification

26-Feb-2010 - Germany

Leukocare AG, a privately-owned company developing innovative biofunctional surfaces using its proprietary stabilizing postcoating technology, announced that it has successfully established a Quality Management System (QMS) in accordance with ISO 9001:2008 and ISO 13485:2003 standards for medical devices.

In order to achieve ISO standards, LEUKOCARE implemented a QMS for its operations to ensure consistent and high quality of the company’s development processes. KEMA Quality B.V. audited LEUKOCARE for the design, development, manufacturing and distribution of technologies and products for biofunctional surface engineering and stabilisation of biomolecules in the field of medical devices, diagnostics, research products and biopharmaceuticals.

“By achieving ISO certification, LEUKOCARE can now offer full quality assurance in terms of development and implementation of our postcoating technology”, stated Michael Scholl, CEO of LEUKOCARE. “We are developing our technology for additional product ranges and this requires us to operate only on the highest standards of international quality.”

Other news from the department politics & laws

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures
View topic world

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures

Topic world biopharmaceutical manufacturing

Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.

20+ products
15+ brochures
View topic world

Topic world biopharmaceutical manufacturing

Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.

20+ products
15+ brochures